In November of 2022, one of Molecular You’s clients received disturbing news—the results of her most recent Molecular You test revealed that she had a high risk of pancreatic cancer, despite showing no symptoms. Her clinician was provided the results of this test and ordered imaging which revealed small lesions. The biopsy indicated it was Stage I pancreatic cancer. Most pancreatic cancers are considered a death sentence since, in a vast majority of diagnoses, they are late-stage. Fortunately, given the early stage of the disease, she was successfully treated and is now cancer free.
This highlights a key issue with our current approach to healthcare; the lack of visibility into our own state of health has created a system focused on reactive, resource-intensive treatments for advanced conditions rather than early detection and prevention of disease. Molecular You, a Vancouver-based predictive health analytics company, has stepped up to address this issue. By combining scientific excellence with data science and AI expertise, Molecular You can spot early warning signs of disease that were previously invisible.
Molecular You’s approach begins with collecting blood test data from individuals. Through advanced laboratory techniques, they analyze over 250 of the individual’s metabolomic, proteomic, and environmental exposures (exposomic) biomarkers to gain a comprehensive understanding of their unique molecular profile that spans 26 biological systems in the body.
This large data set is then processed using sophisticated data science algorithms and AI models. These algorithms are designed to identify patterns, correlations, and predictive indicators within the vast Molecular You data systems. By leveraging machine learning techniques, Molecular You uncovers hidden insights and can accurately assess an individual’s current health risks and potential future health conditions. With these insights and early detections, people can have earlier interventions and minimize or even avoid disease impact, improving health and lowering medical costs.
Applying these deep-dive health predictions across any given population gives organizations a more accurate forecast of healthcare costs while allowing them to share in improving an individual’s health, engagement, and reduced healthcare expenses. For a health plan manager, this comprehensive approach helps eliminate the gap in health visibility that currently exists between stale data sources, like claims, and a person’s actual health.
Another key advantage of Molecular You’s approach is its ability to engage individuals in preventive health. Based on the insights gained from the analysis, Molecular You provides actionable recommendations tailored to each individual’s unique profile, including diet, exercise, lifestyle modifications, and targeted interventions. By empowering individuals with actionable insights, Molecular You aims to support proactive decision-making and enable individuals to take control of their health and live a more productive life.
Molecular You is paving the way for a future where we have a transparent view of a person’s true health status at a molecular level, seeing things that were previously invisible and reliably assessing future disease risk. These individuals roll up into aggregate groups to help organizations understand their population’s health, accurately predict and then drive down healthcare spending, and foster more engaged, healthier people. To learn more about Molecular You and its planned expansion into the US, visit www.molecularyou.com/us.
